Article

Resolution of Tinea Pedis With Imiquimod Cream 5% in a Patient With Nodular Basal Cell Carcinoma

Cutis. 2006 July;78(1):66-69
By
Stashower ME
Author and Disclosure Information

A 73-year-old white man with nodular basal cell carcinoma (nBCC) of the toe and interdigital tinea pedis was treated with imiquimod cream 5% once daily for 4 weeks and twice daily for 10 weeks. Results of a posttreatment potassium hydroxide (KOH) preparation and biopsy confirmed clearance of both tinea pedis and nBCC, respectively.
PDF Download

 

Recommended Reading

Atrophic Dermatofibrosarcoma Protuberans: A Case Report and Reappraisal of the Literature
MDedge Dermatology
Merkel Cell Carcinoma: A Case Report With Treatment Summary and Updates
MDedge Dermatology
Eosinophilic Fasciitis (Shulman Syndrome)
MDedge Dermatology
Metastatic Gastric Adenocarcinoma Presenting as an Enlarging Plaque on the Scalp
MDedge Dermatology
The Use of Topical Imiquimod for the Treatment of Actinic Keratosis: A Status Report
MDedge Dermatology
Angiosarcoma: A Case Report and Review of the Literature
MDedge Dermatology
Syringomatous Carcinoma in a Young Patient Treated With Mohs Micrographic Surgery
MDedge Dermatology
Primary Cutaneous Adenoid Cystic Carcinoma: A Case Report and Literature Review
MDedge Dermatology
Superior Vena Cava Syndrome: A Case Report
MDedge Dermatology
Bednar Tumor: Treatment With Mohs Micrographic Surgery
MDedge Dermatology